ロード中...
Inhaled Formoterol-Fluticasone Single Inhaler Therapy in Asthma: Real-World Efficacy, Budget Impact, and Potential to Improve Adherence
Asthma is the commonest chronic disease affecting airways in humans and has an increasing global disease burden. Inhaled corticosteroids (ICS) are the first-line therapeutic option for asthma, and addition of a long-acting beta 2-agonist (LABA) has been shown to improve asthma control. A combination...
保存先:
| 出版年: | Can Respir J |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7509561/ https://ncbi.nlm.nih.gov/pubmed/33005277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8631316 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|